InnoStar Bio-Tech Nantong Company, Ltd – 11/1/2024
InnoStar Bio-Tech Nantong Company, Ltd – 11/1/2024. Country: United States. Record Type: Response to Form 483
-
-
Koikoi Trading Inc., Issues Allergy Alert on Undeclared Wheat and Sesame in FU ZHOU FISH BALL (200g / 400g / 5lb)
Commerce, CA – Koikoi Trading Inc. is recalling certain lots of FU ZHOU FISH BALL products in multiple pack sizes (200g, 400g, and 5LB) because the products may contain undeclared allergens: wheat and sesame. People who have an allergy or severe sensitivity to wheat and/or sesame run the risk of a s -
Gerber Products Company Announces Voluntary Recall of Limited Batches of Arrowroot Biscuits Out of an Abundance of Caution Due to Potential Presence of Foreign Material Following Supplier Recall
January 26, 2026 — Gerber Products Company is initiating a voluntary recall of limited batches of Gerber® Arrowroot Biscuits out of an abundance of caution due to the potential presence of soft plastic and/or paper pieces that should not be consumed. The material comes from an arrowroot flour suppli -
Class 4 Medicines Defect Notification: Viatris Products Ltd, Arixtra solution for injection, pre-filled syringes, EL(26)A/04
Viatris has received reports of brown discolouration and blockage in the needle of pre-filled syringes of Arixtra. This quality defect is related to oxidation of the syringe needle.
-
Fulijaya Manufacturing SDN. BHD. – 719172 – 01/14/2026
CGMP/Finished Pharmaceuticals/Adulterated -
Center For Immunology Science, LLC – 719933 – 01/13/2026
Sponsor/Investigator -
Field Safety Notices: 19 to 23 January 2026
List of Field Safety Notices from 19 to 23 January 2026.
-
Empower Clinic Services LLC dba Empower Pharma. Houston, TX. 483 issued 12/14/2025
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 12/14/2025
Short Title (70 char) Empower Clinic Services LLC dba Empower Pharma. Houston, TX. 483 issued 12/14/2025
FEI Number 3011887629
Firm Name Empower Clinic Services LLC dba Empower Pharma
Record Type 483 -
MHRA Safety Roundup: January 2026
Summary of the latest safety advice for medicines and medical device users
-
Decision: Marketing authorisations Granted in 2026
Marketing authorisations Granted in 2026.
-
Decision: Parallel import licences granted in 2026
Parallel import licences granted in 2026.
-
MHRA issues new guidance for people using mental health apps and technologies
New online resources will help the public, parents, carers and health, social care and education professionals understand what safe, effective digital mental health technologies look like in practice.